Maarten van der Doelen

Immunophenotyping during radium-223 therapy in mCRPC patients

ACKNOWLEDGEMENTS We thank all patients and their families who participated in this study. We thank Merijn Janssen, Marga Ouwens, Marjo van de Ven, Maarten de Bakker, and Maarten Vinken for the collection of the blood samples. FUNDING This research was partly funded by Bayer The Netherlands. The funding organization had no role in the design and conduct of the study, collection, management, analysis, interpretation of the data, and preparation, review, or approval of the abstract or the manuscript.

3

69